ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia

被引：8
|
作者：
Otto, N. [1 ]
Manukjan, G. [1 ]
Goehring, G. [1 ]
Hofmann, W. [1 ]
Scherer, R. [2 ]
Luna, J. Chacon [1 ]
Lehmann, U. [3 ]
Ganser, A. [4 ]
Welte, K. [5 ]
Schlegelberger, B. [1 ]
Steinemann, D. [1 ]
机构：
[1] Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany
[2] Hannover Med Sch, Inst Biometry, D-3000 Hannover, Germany
[3] Hannover Med Sch, Inst Pathol, D-3000 Hannover, Germany
[4] Hannover Med Sch, Dept Haematol Haemostasis Oncol & Stem Cell Trans, D-3000 Hannover, Germany
[5] Hannover Med Sch, Ctr Paediat & Adolescent Med & Dermatol, D-3000 Hannover, Germany
来源：
LEUKEMIA | 2011年 / 25卷 / 07期
关键词：
SEQUENCE-BINDING-PROTEIN; MYELOGENOUS LEUKEMIA; CELLS; EXPRESSION; GENE; APOPTOSIS; TRANSCRIPTION; SURVIVAL; MUTATION; MICE;
D O I：
10.1038/leu.2011.61
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1202 / 1207
页数：6
相关论文
共 50 条
  • [21] Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia
    Johan, MF
    Bowen, DT
    Frew, ME
    Goodeve, AC
    Reilly, JT
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (01) : 60 - 65
  • [22] Erratum to Azacitidine: a review of its use in the management of myelodysplastic syndromes/acute myeloid leukaemia
    G. M. Keating
    Drugs, 2012, 72 : 1578 - 1578
  • [23] Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemia
    Johan, MF
    Bowen, DT
    Frew, ME
    Goodeve, AC
    Wilson, GA
    Peake, IR
    Reilly, JT
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (06) : 843 - 844
  • [24] DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia
    Norio, Shiba
    Taki, Tomohiko
    Park, Myoung-ja
    Shimada, Akira
    Sotomatsu, Manabu
    Adachi, Souichi
    Tawa, Akio
    Horibe, Keizo
    Tsuchida, Masahiro
    Hanada, Ryoji
    Tsukimoto, Ichiro
    Arakawa, Hirokazu
    Hayashi, Yasuhide
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (03) : 413 - 414
  • [25] Methylation pattern of preferentially expressed antigen of melanoma in acute myeloid leukemia and myelodysplastic syndromes
    Qin, Ya-Zhen
    Zhang, Yan-Huan
    Qin, Xiao-Ying
    Zhu, Hong-Hu
    ONCOLOGY LETTERS, 2017, 13 (04) : 2823 - 2830
  • [26] Acute myeloid leukaemia following myelodysplastic syndrome
    Divane, A.
    Paterakis, G.
    Chantzi, F.
    Kitra, V.
    Karamolegou, K.
    Sandu-Tsoutsou, A.
    Georgakopoulos, N.
    Moschovi, M.
    CHROMOSOME RESEARCH, 2009, 17 : 145 - 145
  • [27] Myelodysplastic syndrome or acute myeloid leukaemia with olaparib
    Reactions Weekly, 2021, 1856 (1) : 3 - 3
  • [28] AzacitidineA Review of its Use in Higher-Risk Myelodysplastic Syndromes/Acute Myeloid Leukaemia
    Gillian M. Keating
    Drugs, 2009, 69 : 2501 - 2518
  • [29] Therapeutic targeting of NF-κB in myelodysplastic syndromes and acute myeloid leukaemia - the biological heterogeneity
    Bruserud, Oystein
    Reikvam, Hakon
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (11) : 1139 - 1142
  • [30] Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?
    Bigenwald, Camille
    Harel, Stephanie
    Chevignon, Florian
    Roos-Weil, Damien
    Bernard, Olivier A.
    Amorim, Sandy
    Brice, Pauline
    Ades, Lionel
    Nloga, Anne Marie
    Sebert, Marie
    Braun, Thorsten
    Eclache, Virginie
    Thieblemont, Catherine
    Fenaux, Pierre
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (02) : 304 - 308
12345